ExoCoBio takes in $27 mln Series B
South Korea-based ExoCoBio Inc, an exosome startup, has raised about $27 million in Series B funding. The investors included Seven Tree Equity Partners, Csquared Global Asset Management, TS Investment Partners, K2 Investment, Intervest, KDB Capital, Atinum Investment, GU Equity Partners and Quantum Ventures Korea.
12 September 2018•1 min read
